Mabapi le kankere / kalafo / lithethefatsi / liphio

Lithethefatsi li Amoheloa Kankere ea Liphio (Renal Cell)

Leqephe lena le thathamisa lithethefatsi tsa mofets'e tse amoheloang ke Tsamaiso ea Lijo le Lithethefatsi (FDA) bakeng sa mofetše oa liphio (renal cell). Lethathamo lena le kenyelletsa mabitso a tlhaho le mabitso a mabitso. Mabitso a lithethefatsi a hokahana le kakaretso ea tlhaiso-leseling ea lithethefatsi ea Cancer ea NCI. Ho kanna ha ba le lithethefatsi tse sebelisoang mofetseng oa liphio (renal cell) tse sa thathamisoang mona.

Lithethefatsi li Amoheloa Kankere ea Liphio (Renal Cell)

Motlatsi (Everolimus)

Mofani oa Disperz (Everolimus)

Aldesleukin

Avastin (Bevacizumab)

Avelumab

Axitinib

Bavencio (Avelumab)

Bevacizumab

Cabometyx (Cabozantinib-S-Malate)

Cabozantinib-S-Malate

Everolimus

EA-2-Aldesleukin

Mongolo wa Inlyta (Axitinib)

Interleukin-2 (Aldesleukin)

Ipilimumab

Keytruda (Pembrolizumab)

Lenvatinib Mesylate

Lenvima (Lenvatinib Mesylate)

Mvasi (Bevacizumab)

Nexavar (Sorafenib Tosylate)

Nivolumab

Opdivo (Nivolumab)

Pazopanib Hydrochloride

Pembrolizumab

Proleukin (Aldesleukin)

Sorafenib Tosylate

Sunitinib Malate

Sutent (Sunitinib Malate)

Temsirolimus

Torisel (Temsirolimus)

Votrient (Pazopanib Hydrochloride)

Yervoy (Ipilimumab)